Results 181 to 190 of about 57,833 (235)

Bullous Systemic Lupus Erythematosus as a Marker of Treatment-Refractory Systemic Disease: A Case Report. [PDF]

Cureus
Izadian Bidgoli A, Gomez Veliz A, Mathew J, De Guzman J, Yazdanpanah S, Joshi A.   +5 more
europepmc   +1 more source

Lupus Erythematosus Tumidus Mimicking Erythema Nodosum: A Diagnostic Challenge. [PDF]

Cureus
Aung T, Eblen K, Pierce J, Gates G.
europepmc   +1 more source

Chilblain lupus: A rare form of cutaneous lupus erythematosus - A case report. [PDF]

SAGE Open Med Case Rep
Perazzolli G, Banchetti E, Melis E, Carletto A, Girolomoni G, Gisondi P.   +5 more
europepmc   +1 more source

Hydroxychloroquine Patch Test Positivity in a Patient With Systemic Lupus Erythematosus

Contact Dermatitis, Volume 95, Issue 2, Page 231-233, August 2026.
Alexa G. Ries, Zachary Frost, Zachary Hopkins, Jamie P. Schlarbaum   +3 more
wiley   +1 more source

Clinical Images: Biopsy-proven hydroxychloroquine-induced cardiomyopathy in an adolescent with systemic lupus erythematosus. [PDF]

Arthritis Rheumatol
Mastrangelo G, Levy DM, Nagy A, Jeewa A.
europepmc   +1 more source

Hearing Loss in Systemic Lupus Erythematosus: a Systematic Review. [PDF]

Maedica (Bucur)
Hanna Y, Tlais M, Natour D, Mazraani Y, Obeid N, Sarraf G, Zalzali I, Moghnie Y, Harouny T, Chebbo H, Farhat H.   +10 more
europepmc   +1 more source

Inverse association between hydroxychloroquine use and depressive symptoms in systemic lupus erythematosus: a single-center cross-sectional study. [PDF]

BMC Rheumatol
Wang X, Yang L, Gu B, Ren Q, Su D, Che N.   +5 more
europepmc   +1 more source

Aggressive squamous cell carcinomas arising from mucosal lichen planus: A report of three cases

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 8, Page e1129-e1132, August 2026.
Neda Cramer, Dagmar Wilsmann‐Theis, Michael P. Schön, Jörg Wenzel, Julia Gallwas, Rotraut Mössner   +5 more
wiley   +1 more source

Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma. [PDF]

J Immunother Cancer
O'Reilly EM, Cabanski CR, Lyman JP, Wainberg ZA, Fisher GA, Wolff RA, Ko AH, O'Hara MH, Spencer CN, Yu JX, Da Silva DM, Padrón LJ, Arnott J, Fairchild J, Moore JS, Peng B, Hoos WA, O'Donnell-Tormey J, Boffo S, Dugan U, Kimmelman AC, Amaravadi RK, Vonderheide RH.   +22 more
europepmc   +1 more source